|
Volumn 40, Issue 4, 2001, Pages 315-323
|
Protection of nigral neurons by GDNF-engineered marrow cell transplantation
|
Author keywords
Bone marrow; GDNF; Gene therapy; MPTP; Parkinson; Transplantation; Tyrosine hydroxylase
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
COMPLEMENTARY DNA;
GENE PRODUCT;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
TYROSINE 3 MONOOXYGENASE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BEHAVIOR;
BONE MARROW CELL;
CELL TRANSPLANTATION;
CONTROLLED STUDY;
DISEASE COURSE;
DONOR;
DRUG INDUCED DISEASE;
FEMALE;
GENE TRANSFER;
HYPERACTIVITY;
IMMUNOCOMPETENT CELL;
MALE;
MOTOR ACTIVITY;
NERVE CELL;
NEUROPROTECTION;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
SUBSTANTIA NIGRA;
ANIMALS;
BEHAVIOR, ANIMAL;
BONE MARROW CELLS;
BONE MARROW TRANSPLANTATION;
CELLS, CULTURED;
DNA, COMPLEMENTARY;
DOPAMINE;
FEMALE;
GENE THERAPY;
GENETIC VECTORS;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
IMMUNOHISTOCHEMISTRY;
MALE;
MICE;
MICE, INBRED C57BL;
MOTOR ACTIVITY;
NERVE GROWTH FACTORS;
NERVE TISSUE PROTEINS;
NEURONS;
NEUROPROTECTIVE AGENTS;
PARKINSONIAN DISORDERS;
RECOVERY OF FUNCTION;
SUBSTANTIA NIGRA;
TRANSFECTION;
TYROSINE 3-MONOOXYGENASE;
|
EID: 0034895752
PISSN: 01680102
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-0102(01)00242-5 Document Type: Article |
Times cited : (82)
|
References (35)
|